طالب صيدلاني - Pharmacist | Telegram Webview: PharmaYemen/3591 -

Forwarded from الصيدلاني السريري / عمـر الصباري (الصيدلاني السريري/ عمر الصباري)

😁 كل كتب المعالجه السريريه المحدثه ال:
Pharmacotherapy handbook
Pharmacotherapy apathophysiology
Pharmacotherapy Principles and Practices
❌ تخطئ في وضع دواء ال(Gentamicin) في معالجة
ال(Acute pyelonephritis) في الحوامل.
مع انه من قبل خمس سنوات تم تصنيف دواء(Gentamicin)
في الحوامل كلاس(D).
🧡 تحيه لكتاب كودا كيمبل(Applied therapeutics).
كان في (2013) واضع دواء ال(Gentamicin) آمن للحامل
في معالجة ال(Acute pyelonephritis).
وفي تحديث ال(applied therapeutics11) لعام (2018)
لم يضع دواء(Gentamicin) في
معالجة ال(Acute pyelonephritis) عند الحوامل.
الصيدلانــــــي السريــــري / عمــــــــر الصبــــــــــاري
https://www.facebook.com/AlsubariOmar
www.tg-me.com/OmarAlsubari

www.tg-me.com/cn/طالب صيدلاني Pharmacist/com.PharmaYemen/3591

3.2K viewsالصيدلاني السريري/ عمر الصباري, Mar 17, 2022 at 18:45

tg-me.com/PharmaYemen/3591

Create: 2022-03-17
Last Update: 2025-04-17 14:29:35

BY طالب صيدلاني - Pharmacist

Share with your friend now:
tg-me.com/PharmaYemen/3591

طالب صيدلاني Pharmacist Telegram | DID YOU KNOW?

Tata Power whose core business is to generate, transmit and distribute electricity has made no money to investors in the last one decade. That is a big blunder considering it is one of the largest power generation companies in the country. One of the reasons is the company's huge debt levels which stood at ₹43,559 crore at the end of March 2021 compared to the company’s market capitalisation of ₹44,447 crore.

However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.